Cargando…

Circulating microRNAs as biomarkers for diabetic neuropathy: A novel approach

Oxidative stress stemming from tissue exposure to constant hyperglycemia is one of the major pathogenetic pathways of diabetic macro- and microvascular complications. Diabetic polyneuropathy, commonly manifesting as distal, symmetrical sensorimotor polyneuropathy, is characterized by progressive sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xourgia, Eleni, Papazafiropoulou, Athanasia, Melidonis, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305524/ https://www.ncbi.nlm.nih.gov/pubmed/30596030 http://dx.doi.org/10.5493/wjem.v8.i3.18

Ejemplares similares

Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron
por: Xourgia, Eleni, et al.
Publicado: (2019)

Effects of antidiabetic drugs on epicardial fat
por: Xourgia, Eleni, et al.
Publicado: (2018)

Effect of 3-month α-lipoic acid treatment on sural nerve conduction velocity and amplitude in patients with diabetic neuropathy: a pilot study
por: Papazafeiropoulou, Athanasia, et al.
Publicado: (2019)

Role of circulating microRNAs in liver diseases
por: Loosen, Sven H, et al.
Publicado: (2017)

Circulating microRNAs as potential new biomarkers for prostate cancer
por: Sita-Lumsden, A, et al.
Publicado: (2013)

Effects of Chios mastic gum on cardiometabolic risk factors
por: Papazafiropoulou, Athanasia K
Publicado: (2022)

Type 2 diabetes and quality of life
por: Trikkalinou, Aikaterini, et al.
Publicado: (2017)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

MicroRNAs sound off
por: Weston, Michael D, et al.
Publicado: (2009)

The role of microRNAs in glucocorticoid action
por: Clayton, Sally A., et al.
Publicado: (2018)

Role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment
por: Florentin, Matilda, et al.
Publicado: (2022)

Diabetes and dementia – the two faces of Janus
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2020)

The role of microRNAs in liver cancer progression
por: Huang, S, et al.
Publicado: (2011)

Prevalence of Erectile Dysfunction among Greek Men with Type 2 Diabetes Mellitus
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2020)

MicroRNAs in cell proliferation, cell death, and tumorigenesis
por: Hwang, H-W, et al.
Publicado: (2006)

Robust and specific inhibition of microRNAs in Caenorhabditis elegans
por: Kundu, Samrat T, et al.
Publicado: (2010)

MicroRNAs: new players in acute myeloid leukaemia
por: Havelange, V, et al.
Publicado: (2009)

Urinary MicroRNA as Biomarker in Renal Transplantation
por: van de Vrie, M., et al.
Publicado: (2016)

Advances in cardiovascular-related biomarkers to predict diabetic peripheral neuropathy
por: Cheng, Meng-Ke, et al.
Publicado: (2023)

Augmentation index as an early marker of in-hospital mortality in patients with acute ischemic stroke
por: Papazafiropoulou, Athanasia, et al.
Publicado: (2019)

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
por: Pichler, M, et al.
Publicado: (2015)

Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy
por: Fan, Baoyan, et al.
Publicado: (2020)

Roles of Wnt/β-catenin signaling pathway related microRNAs in esophageal cancer
por: Chu, Chao-Yang, et al.
Publicado: (2022)

Circulating MicroRNAs as Biomarkers for Sepsis
por: Benz, Fabian, et al.
Publicado: (2016)

MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma
por: Espelt, María V, et al.
Publicado: (2019)

Circulating microRNAs as biomarkers for type 1 diabetes mellitus
por: Assmann, Tais Silveira, et al.
Publicado: (2015)

Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers
por: Dorval, Véronique, et al.
Publicado: (2013)

Prevalence and correlates of sleep disorders in Greek patients with type 2 diabetes: comparison of an urban and a semi-urban population
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2020)

Effect of 3-Month Therapy with Empagliflozin on Ambulatory Blood Pressure and Arterial Stiffness in Patients with Type 2 Diabetes Mellitus
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Circulating MicroRNAs: Potential Biomarkers for Cancer
por: Yu, De-Cai, et al.
Publicado: (2011)

Circulating microRNAs as biomarkers - True Blood?
por: Schöler, Nathalie, et al.
Publicado: (2011)

Circulating MicroRNAs as Biomarkers of Acute Stroke
por: Sepramaniam, Sugunavathi, et al.
Publicado: (2014)

MicroRNA in lung cancer
por: Lin, P-Y, et al.
Publicado: (2010)

Circulating MicroRNAs as Biomarkers of Gestational Diabetes Mellitus: Updates and Perspectives
por: Guarino, Elisa, et al.
Publicado: (2018)

Erratum: Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers
por: Dorval, Veronique
Publicado: (2013)

Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy
por: Wang, Jun, et al.
Publicado: (2015)

Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
por: Hamam, Rimi, et al.
Publicado: (2017)

Determinants of Functional MicroRNA Targeting
por: Hwang, Hyeonseo, et al.
Publicado: (2023)

Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications
por: Duque, Alice, et al.
Publicado: (2021)

Altered Circulating microRNAs in Patients with Diabetic Neuropathy and Corneal Nerve Loss: A Pilot Study
por: Khan, Adnan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vgegirnbt58a5a50omb5sqc2hu